Drug intelligence / Profile preview

Stevit Tablets

Development stage: Unknown
Lead developer: Stevia Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Stevit Tablets is an oral multivitamin and mineral supplement developed and marketed by Stevia Pharmaceuticals in India. The product is primarily indicated for the management and prevention of multivitamin and mineral deficiencies. Its formulation contains essential trace minerals, specifically elemental copper (0.9 mg) and elemental manganese (2 mg). Copper is a critical cofactor for several enzymes involved in energy production, iron metabolism, and connective tissue synthesis, while manganese is essential for bone formation, blood clotting, and antioxidant defense. As a small molecule nutritional supplement, Stevit Tablets works by replenishing these micronutrients to maintain physiological homeostasis and support overall metabolic health.

Brand names: Stevit Tablets
Other names: Stevit

Beyond the preview

Go deeper on Stevit Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stevit Tablets.

Explore the full profile